The conference featured comprehensive discussions, field visits, and knowledge-sharing sessions addressing different aspect of major NCDs
Final decision from the European Commission is anticipated within the coming months
Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept
The funds raised from the Whitathon run are utilized to treat underprivileged children suffering from Retinoblastoma
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
In the Phase 3 LIBRETTO-431 study, Retevmo more than doubled progression-free survival (PFS) compared to chemotherapy plus pembrolizumab in patients with advanced or metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC)
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Subscribe To Our Newsletter & Stay Updated